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Methods: A cross-sectional study enrolled 200 children and adolescents with attention-
deficit/hyperactivity disorder visiting four Chinese tertiary care psychiatric clinics to assess the validity
and reliability of the Dundee difficult times of the day scale (D-DTODS), using the Weiss functional
impairment rating scale for parents form (WFIRS-P) and the Swanson, Nolan and Pelham, version IV
26-item teacher and parent rating scale (SNAP-IV-26). Results: The calculated Cronbach’s-α for the
D-DTODS total score was 0.793. The calculated Spearman’s correlation coefficients for D-DTODS versus
WFRIS-P and Swanson, Nolan and Pelham, version IV 26-item teacher and parent rating scale (SNAP-IV-26)
were 0.425 (p < 0.01) and 0.452 (p < 0.001), respectively. Conclusion: The D-DTODS was worth future
test–retest confirmation regarding reliability and validity for assessing functional impairment associated
with attention-deficit/hyperactivity disorder across different time periods of the day in Chinese children
and adolescents.
First draft submitted: 6 September 2018; Accepted for publication: 29 October 2018; Published online:
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Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder [1]. Onset of
ADHD usually occurs in childhood and is characterized by excessive activity, difficulty in paying attention and
impulsivity, and is associated with a range of negative outcomes including challenges associated with developing
interpersonal relationships [1]. The prevalence of ADHD in Chinese children and adolescents is around 6.3%, with
attention deficit as the main ADHD subtype [2]. ADHD is associated with symptoms and functional impairment
across the whole day, including during daytime at school and in the early mornings, late afternoon and evenings at
home [3]. Because the tasks and demands on the child vary by setting, parent rating scales for ADHD play crucial
roles in estimating symptom severity and assessing treatment response for optimal management of ADHD [4]. The
most commonly used parent rating scales for ADHD in China include the Swanson, Nolan and Pelham, version IV
26-Item Teacher and Parent Rating Scale (SNAP-IV-26), a measure of ADHD symptoms, and theWeiss functional
impairment rating scale for parents form (WFIRS-P), a measure of ADHD-specific impairment [5–7]. However,
these two rating scales were designed for the general assessment of ADHD but not for disease assessment during
specific time periods of the day. With the recognition of the significant clinical implications of ADHD-related
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symptoms and functional impairment across the day [8], all-day ADHD management, including medication to
cover evenings and weekends when at home, has been recommended by the American Academy of Pediatrics clinical
practice guideline to minimize the burden of ADHD on patients, their families and society in general [9]. However,
well-established parent rating scales that can assess the burden of ADHD across specific time periods throughout
the day are lacking in China.
The Dundee difficult times of the day scale (D-DTODS) is a clinical tool developed at the University of Dundee
to aid communication between clinicians and parents of children with ADHD [10]. D-DTODS asks about ten
specific time points during the day and asks parents to assess the difficulties associated with ADHD for children
at home and at school during these time periods. Ratings are based on an average day over the last month. Thus,
D-DTODS can be used as a parent rating scale to assess the fluctuation of problems across the day and to assist
the clinician in identifying the clinical needs for all-day ADHD management. D-DTODS has been used as a
measurement to assess the efficacy of interventions, including coaching [11] and pharmacotherapy [12], for ADHD
across the day. However, the reliability and validity of D-DTODS have not been well established. By contrast
to the SNAP-IV-26 and WFIRS-P, D-DTODS was specifically designed to measure the functional impairment
associated with ADHD throughout the day and to meet the medical needs of monitoring ADHD and tailoring
ADHDmanagement throughout the day. Additionally, it takes less than 5 min to complete the D-DTODS, which
has simple and friendly graphics that make it easy-to-use and increase the generalizability across different clinical
settings and countries. These features make the D-DTODS potentially very suitable for busy clinic settings in
China where the conventional rating scales are often seen as too long and complex for day-to-day use. As the
D-DTODS has not thus far been evaluated with regards to validity and reliability, we conducted this study to
assess these factors and determine the potential clinical utility of the D-DTODS for all-day ADHD assessment in
Chinese children and adolescents.
Materials & methods
This study was a cross-sectional study recruiting children and adolescents with ADHD from well-established
psychiatric clinics in four Chinese cities to assess the validity and reliability of D-DTODS. As there are no
established Chinese rating scales for the assessment of ADHD across different time periods of the day, two validated
ADHD rating scales (SNAP-IV-26 and WFIRS-P) for the general assessment of ADHD symptoms and functional
impairments were selected as the reference scales to validate D-DTODS. All ratings were made by parents. This
study was conducted under the ethics approval from the four study sites. Study participation consent was required
from the parents of the enrolled children with ADHD.
Patient enrollment
Patients were enrolled from four child and adolescent psychiatry clinics at four tertiary care hospitals in Beijing,
Shanghai, Nanjing and Changsha. The patient enrollment was conducted in routine clinical practice at these clinics.
This study included patients aged between 6 and 18 years who had a clinical diagnosis of ADHD according to the
Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria [3]. Patients were excluded
if they had any of the following comorbidities: nervous system degenerative disease, brain trauma, cerebral palsy,
epilepsy, bipolar disorder, schizophrenia, substance abuse, psychotic disorder or other severe psychiatric disorders.
The parents of the enrolled children with ADHD signed the printed study consent to finalize patient enrolment.
Study package
A study package was developed to facilitate data collection. The study package consisted of a study-specific
data collection form and the Chinese versions of D-DTODS, WFIRS-P and SNAP-IV-26. The data collection
form was designed to collect the characteristics of the enrolled children and adolescents (demographics, school
status, family environment, ADHD diagnosis and ongoing treatment, and mental comorbidities) and their parents
(social economic status, lifestyle, pregnancy, birth delivery mode and infant feeding source). The study psychiatrists
completed the data collection form by assessing the included children and adolescents with ADHDand interviewing
their parents. The D-DTODS was translated to Chinese using a forward-and-back translation approach. Approval
for use of the D-DTODS was obtained from the University of Dundee. The Chinese versions of WFIRS-P and
SNAP-IV-26 were previously validated [6,7]. The three rating scales were completed by the parents of the included
children and adolescents with ADHD. The collected data and completed rating scales in the study packages were
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transferred to an electronic database developed by EpiData software. All entered electronic data were verified by an
independent quality assurance associate.
The rating scales
D-DTODS consisted of ten items that were rated by four scores from 1 to 4 (1: no difficulties; 4: the most
difficulties) to assess the difficulty of activities for ‘morning before school’ (items 1–3), ‘in school’ (items 4–6),
‘after school’ (item 7), ‘school homework’ (item 8) and ‘bedtime’ (items 9 & 10). The total score of D-DTODS
was calculated by the sum of the subscore of the 10 items. SNAP-IV 26 included three subsets to assess the severity
of symptoms for inattention (items 1–9), hyperactivity/impulsivity (items 10–18) and oppositional criteria (items
19–26) [13]. Subscale scores on the SNAP-IV 26 are calculated by summing the scores of the items in the same
subset. To specifically address overall symptoms of ADHD, the subsets of inattention and hyperactivity/impulsivity
were combined to calculate a total score for ADHD. WFIRS-P included five domains including family, school, life
skills, child’s self-concept, social activities and risky activities [14]. Each domain of WFIRS-P consists of ten items.
The subscale score for each domain was calculated by dividing the summed items scores by the number of items in
the same domain.
Statistical analysis
A total of 200 patients were planned to be enrolled in order to make sure that the item subject ratio was >20
and an absolute minimum was >100 patient. Each study site was assigned to enrol 50 eligible patients. The
characteristics of included children with ADHD and their parents were summarized using descriptive statistical
methods. The internal consistencies of D-DTODS were measured by Cronbach’s-α [15], which was calculated for
all items and also the items within the same subset. The convergent validity of D-DTODS was assessed through the
Spearman’s correlations between overall or subscale scores associated with the two criteria rating scales. To explore
the discrimination threshold of D-DTODS for determining ADHD severity, the receiver-operating characteristic
(ROC) analysis method was used by using a binary classifier system with each D-DTODS cut-off score, which
increased by five points from 0 to 40 to detect significant ADHD defined by SNAP-IV 26 mean score of item 1–18
(<1.67 for insignificant ADHD symptom vs ≥1.67 for significant ADHD symptom in top 5% of the average
rating per item score in the patients with ADHD) [16] and WFIRS-P score (none of the question items scored 3 for
insignificant function impairment vs at least one question item scored 3 for significant functional impairment) [17],
respectively. The sensitivity and specificity associated with each cut-off score of D-DTODS for significant ADHD
symptoms and function impairment were plotted to calculate the area under ROC (AUC). The data analyses were
performed using SAS 9.2 (SAS Inc., NC, USA) and the statistical significance was defined as a two-sided p-value
less than 0.05.
Results
The initial screening identified 270 children and adolescents with suspected ADHD at the four study sites. Further
eligibility assessment excluded 40 patients who didn’t meet the diagnosis criteria of ADHD. An additional 30
patients were excluded because their parents declined the study. A total of 200 children and adolescents with
ADHD were enrolled and included in the final data analysis. The patient enrolment flowchart is illustrated in
Figure 1.
Characteristics of the included patients with ADHD & their parents
Similar to the previously reported demographics of diagnosed patients with ADHD in China [18], the majority of
the 200 included patients with ADHD were elementary school students (76.5%), boys (77.5%) and living in a
single-child family (68.5%). This study cohort was associated with a relatively short mean length of time since the
ADHD diagnosis was made of 62.6 ± 96.6 weeks and mainly included the two ADHD subtypes (inattention:
45.5%; combined inattention and hyperactivity/impulsivity: 49.0%). Ongoing treatment, mainly drug treatment,
was reported in 65.5% of the included patients. The identified main neurodevelopmental and mental health
comorbidities in this study cohort included learning disability (24.5%), oppositional defiant disorder (10.0%) and
tic disorder (10.5%). Additionally, the parents of the included children with ADHD were characterized with high
cesarean rate (49.2%) and low breastfeeding rate (42.7%). The detailed characteristics of the included patients with
ADHD and their parents are summarized in Table 1.
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Initial screening identified 270
children and adolescents with
suspected ADHD
Parents of 230 patients with
confirmed ADHD were invited to
participate study
Final inclusion: 200 ADHD
patients (50 in each study site)
Exclusion of patients whose parents
declined the study (BAH: 8; SMHC: 3;
NBH: 4; SXH: 15)
Exclusion of patients without meeting the
diagnosis criteria of ADHD (BAH: 8;
SMHC: 4; NBH: 8; SXH: 20)
Figure 1. Flowchart of patient enrollment.
ADHD: Attention-deficit/hyperactivity disorder; BAH: Beijing Anding Hospital; NBH: Nanjing Brain Hospital; SMHC:
Shanghai Mental Health Center; SXH: The Second Xiangya Hospital.
The rating scores of D-DTODS, SNAP-IV 26 & WFIRS-P
Of the rated ten items of D-DTODS, item 8 for completing school homework was associated with the highest
score (2.93 ± 0.85) and item 5 for lunchtime was associated with the lowest score (1.59 ± 0.82). The average score
per item of D-DTODS was 2.1 ± 0.53, indicating a certain degree of difficulty associated with daily activities
in the study cohort. The rating results of the ten items of D-DTODS are summarized in Table 2. The average
SNAP-IV 26 total score and mean score for the ADHD items (items 1–18) was 26.5 ± 9.1 and 1.5 ± 0.5,
respectively. The rated subscale of SNAP-IV 26 for inattention subset (items 1–9) was numerically higher than that
for hyperactivity/impulsivity (items 10–18) in the study cohort (15.6 ± 4.8 vs 10.9 ± 6.1). The mean scores per
item associated with the six domains of WFIRS-P ranged from 0.34 (for risky activities) to 1.11 (for life skills). The
average WFIRS-P score per item was 0.81, indicating modest function impairment associated with this ADHD
cohort.
Reliability of D-DTODS
The computed Cronbach’s-α for D-DTODS (0.793) exceeded the generally accepted cut-off of 0.7 for reliability.
Additionally, the computed Cronbach’s-α for the D-DTODS subsets with two or more items were 0.721 for
‘morning before school’, 0.629 for ‘in school’ and 0.709 for ‘before bed’.
Validity of D-DTODS
The Spearman’s correlation analyses observed that the D-DTODS total score, the sum of the ten item scores, was
significantly correlated with both SNAP-IV 26 total score (coefficient 0.452; p < 0.01) and WFIRS-P average
score (coefficient 0.425; p < 0.01; Table 3). The coefficients associated with five D-DTODS subsets for SNAP-IV
26 total score and WFIRS-P average score ranged from 0.256 to 0.377 and from 0.206 to 0.332, respectively.
Further correlation analyses between the subsets of D-DTODS and SNAP-IV 26 observed the strongest correlation
between D-DTODS ‘evening time’ subset and SNAP-IV 26 inattentive subset (coefficient 0.353; p < 0.01).
The D-DTODS ‘evening time’ subset was associated with the strongest correlation with WFIRS-P family subset
(coefficient 0.396; p < 0.01). Additionally, D-DTODS ‘morning before school’ subset had the weakest correlation
with the SNAP-IV 26 total score (coefficient 0.256; p < 0.01) and WFIRS-P average score (coefficient 0.206;
p < 0.01).
Sensitivity & specificity of D-DTODS to detect significant ADHD symptoms & impairment
When using SNAP-IV 26 total score to define significant ADHD symptoms, the cut-off point for the D-DTODS
total score associated with the discrimination cut point was 25, with a sensitivity of 43.3% and specificity of
86.5%. The AUC of ROC for using D-DTODS to detect significant ADHD symptoms was 0.711. When using
the WFIRS-P average score to define significant functional impairment associated with ADHD, the identified
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Table 1. Summary of the characteristics of the included 200 patients with attention-deficit/hyperactivity disorder and
their parents.
Study subjects Variable Mean ± SD (%)
Demographics
Age (years) 10.4 ± 2.66
Male gender 77.5%
Single-child family 68.5%
School status
Kindergarten 1.5%
Elementary school 76.5%
Middle school 17.5%
High school or above 4.5%
Family history of ADHD 9.0%
Disease duration after diagnosis (weeks) 62.6 ± 96.6
ADHD subtype
ADHD patients Combination of inattention and
hyperactivity/impulsivity
49.0%
Inattention 45.5%
Hyperactivity/impulsivity 5.5%
Current ADHD treatment
Any treatment 65.5%
Medications 63.5%
Behavior treatment 8.0%
Parents training 5.0%
School intervention 0.5%
Mental comorbidities
Learning disability 24.5%
Tic disorder 10.5%
Oppositional defiant disorder 10.0%
Personality disorder 5.5%
Stress 5.0%
Birth delivery mode
Vaginal delivery 50.8%
Cesarean delivery 49.2%
Parents of the ADHD patients Infant feeding score
Breast milk 42.7%
Breast milk substitutes 25.6%
Mixed milk 31.7%
ADHD: Attention-deficit/hyperactivity disorder; SD: Standard deviation.
D-DTODS discrimination cut-off point was 20, with a sensitivity of 65.8% and specificity of 64.0%. The AUC
of ROC for D-DTODS was 0.672 for significant functional impairment associated with ADHD. Based on this
assessment, the discrimination cut-off score of D-DTODS for significant ADHD ranged from 20 to 25. The
ROC associated with D-DTODS for the significant ADHD symptoms and functional impairment defined by the
SNAP-IV 26 and WFIRS-P scores are illustrated in Figures 2A&B, respectively.
Discussion
The D-DTODS was originally developed to facilitate communication between parents of children with ADHD
and clinicians to help understand difficulties associated with daily activities of children with ADHD and profile
these across the day. The D-DTODS hasn’t been previously validated for all-day ADHD management. Our study
is the first study to assess validity and reliability of the D-DTODS against two well-established rating scales for the
general assessment of ADHD symptoms and functional impairment. Based on our assessment, D-DTODS was
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Figure 2. ROC curve. Plotted ROC for sensitivity versus 1-specificity associated with D-DTODS total score for the
diagnosis of significant ADHD based on the SNAP-IV 26 (A) and Weiss functional impairment rating scale for parents
form (B). (A) ROC associated with sensitivity versus 1-specificity of D-DTODS for significant ADHD defined by SNAP-IV
26. (B) ROC associated with sensitivity versus 1-specificity of D-DTODS for significant ADHD defined by Weiss
functional impairment rating scale for parents form.
AUC: Area under ROC; D-DTODS: Dundee difficult times of the day scale; ROC: Receiver-operating characteristic;
SNAP-IV 26: Swanson, Nolan and Pelham, version IV 26-item Teacher and Parent Rating Scale.
Validity & reliability of D-DTODS for ADHD Research Article
Table 2. The rating results of Dundee difficult times of the day scale from the 200 included patients with
attention-deficit/hyperactivity disorder.
Testing item Sample size 1 = Easy 2 = A little
difficult
3 = Difficult 4 = Very difficult Mean (SD) Median
Before school
1. Waking up early in the
morning
200 74 (37.0%) 61 (30.5%) 38 (19.0%) 27 (13.5%) 2.09 (1.05) 2
2. Getting up and getting ready
for school
200 81 (40.5%) 65 (32.5%) 41 (20.5%) 13 (6.5%) 1.93 (0.93) 2
3. Getting to school 200 103 (51.5%) 60 (30.0%) 30 (15.0%) 7 (3.5%) 1.71 (0.85) 1
In school
4. Morning lesson 200 28 (14.0%) 56 (28.0%) 84 (42.0%) 32 (16.0%) 2.60 (0.92) 3
5. Lunchtime 200 116 (58.0%) 58 (29.0%) 18 (9.0%) 8 (4.0%) 1.59 (0.82) 1
6. Afternoon lessons 200 25 (12.5%) 67 (33.5%) 84 (42.0%) 24 (12.0%) 2.54 (0.86) 3
After school
7. Getting home from school 200 99 (49.5%) 67 (33.5%) 24 (12.0%) 10 (5.0%) 1.73 (0.86) 2
Evening
8. Completing school homework 200 7 (3.5%) 58 (29.0%) 77 (38.5%) 58 (29.0%) 2.93 (0.85) 3
Before bed
9. Getting ready for bed 200 76 (38.0%) 74 (37.0%) 33 (16.5%) 17 (8.5%) 1.96 (0.94) 2
10. Going to bed and sleeping 200 124 (62.0%) 44 (22.0%) 22 (11.0%) 10 (5.0%) 1.59 (0.88) 1
Overall 200 73.3 (36.7%) 61 (30.5%) 45.1 (22.6%) 20.6 (10.3%) 2.1 (0.53) 20
SD: Standard deviation.
associated with a certain validity and reliability for the assessment of ADHD. Additionally, our study demonstrated
that using the cut-off score of D-DTODS (20–25) could be better at detecting significant impairment associated
with ADHD than detecting the symptoms of ADHD. Thus, combination of D-DTODS and a rating scale for
ADHD symptoms could give a more comprehensive ADHD assessment. Because D-DTODS consists of fewer
items than the standard rating scales, the simple and friendly format of D-DTODS is easy-to-use and the time to
complete D-DTODS could be less than 5 min. Thus, the D-DTODS could be a potential rating scale to support
all-day ADHDmanagement by assessing ADHD during specific time periods across the day at home and in school
from parent’s perspective.
As it is different from SNAP-IV 26 that takes into account the DSM diagnostic criteria of ADHD, and
from the WFIRS-P for which the items were specifically designed to address functional impairments commonly
associated with ADHD [19,20], the D-DTODS comprises much more general items that give an overall impression
of parents’ observation on the daily activities in children with ADHD and how they vary across the day. As a
cross-sectional study, our study didn’t use test–retest method but follow the reliability assessment method, which
calculated the Cronbach’s-α for the internal consistence of the 20 question times in the questionnaire - children
with difficulties (QCD), another rating scale assessing ADHD throughout the day [21]. Because the calculated
Cronbach’s-α associated with D-DTODS total score was above generally accepted cut-off for reliability (0.7) [22]
even under the potential confounding effects associated with the wearing off of the ADHD treatments, which
could lead to more varied functional impairment in the afternoon and evening time of the day. Future studies are
warranted to use a test–retest approach to confirm the reliability of D-DTODS in the patients with ADHD.
The moderate strength of the correlations between D-DTODS total scores and the two rating scales for the
general assessment of ADHD demonstrated that D-DTODS had a certain level of capacity to assess the symptoms
and function impairment associated with ADHD in Chinese children. Because D-DTODS was designed to assess
ADHD across the day but not for general assessment, the differences in the designs of these rating scales were
expected to reduce the correlations. Another rating scale developed to assess ADHD across the day, QCD, was
also associated with moderate correlation (coefficient 0.514) with the rating scale for the general assessment of
ADHD likely due to the same reason. Additionally, 65.5% of the included patients with ADHD were receiving
treatment when our study was conducted. The high medication treatment rate in our study cohort could affect the
correlations between D-DTODS and the two reference rating scales because medications were usually given in the
morning time before school and the variance of treatment effects associated with the wearing off of the medications
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for ADHD across the day could be captured by D-DTODS but not by the two reference rating scales for general
ADHD assessment. Thus, the validity of D-DTODS for ADHD assessment throughout the day using the two
rating scales for general assessment could be underestimated and warrant future research to verify the validity of
D-DTODS using the rating scale, such as QCD, which had a similar design to assess ADHD throughout the day.
The correlation coefficients between D-DTODS and the two standard rating scales were highly comparable.
Because SNAP-IV 26 measures ADHD symptoms, and WFIRS-P is a functional impairment rating scale, this
finding suggests that the ‘difficulty’ rated by the D-DTODS perhaps taps into both the symptoms and functional
impairments associated with ADHD. For example, the difficulty in doing homework can be interpreted as the
function reduction associated with inattentive symptom and also the indicator for the severity of the inattentive
symptom. Thus, the intrinsic correlation between the SNAP-IV 26 andWFIRS-P (r: 0.648; 95%CI: 0.494–0.802)
could be the main reason for the highly comparable validity associated with D-DTODS for the two reference rating
scales. Additionally, the observed variance associated with coefficients between the D-DTODS subsets and the two
reference rating scales may factor the differences in the designs of the three rating scales. For example, the correlation
associated with the D-DTODS subset for the morning activities before school was much weaker than the other
D-DTODS subsets likely due to the lack of assessment for morning activities in both SNAP-IV 26 and WFIRS-P
and/or the comparable difficulties of morning activities between healthy children and ADHD children [3]. One
study assessing the validity and reliability of QCD for the assessment of ADHD across the day, observed similar
impact of ADHD assessment by time periods of the day on the correlation variance across QCD subsets [23]. Thus,
the observed variance of the D-DTODS subscale scores by time domains throughout the day could be considered
as the incremental validity to confirm the variance of ADHD symptoms and functional impairment across the day,
which couldn’t be detected by SNAP-IV 26 and WFIRS-P.
The two criteria rating scales identified the cut-off D-DTODS scores for significant ADHD symptoms and
functional impairment. We recommend using D-DTODS score from 20 to 25 as the discrimination cut-off to
indicate significant ADHD. The patients who had D-DTODS score ≥20 may have more severe ADHD symptoms
and more impaired functions, and therefore require immediate attention from their caregivers. Because D-DTODS
was not designed for the diagnosis but the measurement for the functional impairment during specific time periods
of the day, the cut-off D-DTODS for significant ADHD should not be used for diagnosis but for disease monitoring
and indicating the needs of ADHD management in specific time periods of the day. Thus, the cut-off ADHD
score could be used as an outcome measure to assess the treatment effects as well.
Our study has significant clinical implications given the fact that ADHD management needs a parent rating
scale to monitor disease severity and assess optimal treatment response across the day for optimal management
of ADHD [24]. Even though the current parent rating scales are able to assess both symptoms and functional
impairment of ADHD in both home and school settings, these rating scales were based on the overall observation
and can’t differentiate the disease severity and treatment response across different times in the day and support
timely and accurate adjustment of ADHD management for better outcomes. D-DTODS can meet this clinical
need by measuring the difficulty of general activities across the day and help with tailoring treatment to individual
needs. Thus, D-DTODS could be used by parents and teachers to identify specific problem times during the day
and guide the development of contingency management strategies. The current ADHD medications include both
stimulant and nonstimulant medications, which are different in pharmacology and pharmacokinetics and time
course of actions across the day [25,26]. Using the D-DTODS can help the clinician use these different medication
properties to adjust treatment effects across the day and to meet the clinical needs of patients during the specific
time periods of the day.
As the first study assessing the clinical utility of D-DTODS for ADHD in the Chinese setting, our study was
associated with several limitations to be aware of and addressed. Of the initially identified 230 qualified patients
with ADHD, the parents of 30 patients with ADHD declined our study. Additionally, the parents of the included
children with ADHD from the four large cities were likely to have higher social economic status and be more
active in seeking medical care for their ADHD children than the parents of ADHD children in the Chinese general
setting. For example, the ADHD treatment rate in our study cohort was 63.5%, which is much higher than the
previously reported treatment rate in Chinese children with ADHD [27]. Thus, the selection bias associated with
our study could confound our assessment and also reduce the generalizability of the assessed reliability and validity
of ADHD. Our cross-sectional study design didn’t allow us to use a conventional test–retest method [28] to assess
the internal consistency of D-DTODS and to assess the validity of D-DTODS in a longitudinal setting where the
rating scales are used to assess ADHD treatment effects [29]. Thus, using D-DTODS to assess treatment effects
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in patients with ADHD should be cautioned before the reliability of D-DTODS is well established by test–retest
method. D-DTODSwas originally designed to profile difficulty across the day to ensure that treatments are effective
across the whole day. Thus, future studies are still needed to assess the validity and reliability of D-DTODS in
the patients with ADHD under treatment and support the utilization of D-DTODS to monitor treatment effects
across the day. Finally, the D-DTODS contained the question item regarding the functional impairment at school
where teacher could make more reliable and valid assessment. The D-DTODS was solely assessed by parents who
might reduce the validity and reliability for the ADHD assessment during the time period in school.
In summary, this cross-sectional study was the first study proving that parent-completed D-DTODS was
associated with satisfactory validity and reliability to assess ADHD functional impairments across the day in
Chinese children and adolescents. The clinical utility of D-DTODS to assess ADHD treatment response should
be further evaluated in longitudinal settings for all-day ADHD management.
Summary points
• The first Chinese study validating Dundee Difficult Times of the Day Scale (D-DTODS), a parent rating scale
consisting of ten question items to assess functional impairment associated with attention-deficit/hyperactivity
disorder (ADHD) throughout the day.
• The observed internal consistence associated with the ten question items of D-DTODS warrant future research
using test–retest method to confirm the reliability of D-DTODS for ADHD assessment throughout the day.
• The significant correlation between D-DTODS and the two general rating scales, Swanson, Nolan and Pelham,
version IV 26-item teacher and parent rating scale (SNAP-IV-26) and Weiss functional impairment rating scale for
parents form (WFIRS-P), suggested that D-DTODS was valid to assess the functional impairment associated with
ADHD.
• The varied subscale scores of D-DTODS for the five-time domains throughout the day in the ADHD patients
indicated the variance of the functional impairment of ADHD throughout the day.
• High treatment rate in the study subjects with ADHD could confound the functional impairment of ADHD
throughout the day as the wearing off of the treatments might not be able to control the symptoms and
functional impairment associated with ADHD throughout the day.
• The varied subscale scores of D-DTODS in the study subjects with ADHD supported the needs of monitoring and
managing ADHD throughout the day.
• D-DTODS could be a suitable rating scale to assess functional impairment associated with ADHD throughout the
day in a busy clinical setting.
• D-DTODS should be used as a rating scale for the assessment of functional impairment associated with ADHD
throughout the day but not a diagnosis tool for ADHD.
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